VBL Therapeutics Announces Enrollment of the First Patients in the Phase 2 Clinical Trial of VB-111 in Metastatic Colorectal Cancer

NEXT STORY
NEW RESEARCH SHOWS FIRST 5 LA GRANTEES REDUCING EARLY CHILDHOOD OBESITY IN LOS ANGELES COUNTY
PREV STORY
Medexus Reports Health Canada Approval of Gleolan® (5-ALA) for Use in Guided Surgical Resection of High-Grade Gliomas
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

The Obesity Society Updates Position on Obesity

author_avatar
NASDAQ Market News

Sanofi and Regeneron Announce Positive Phase 2 Study Results for Dupilumab in Patients With Active Moderate-to-Severe Eosinophilic Esophagitis

Sanofi and Regeneron Announce Positive Phase 2 Study Results for Dupilumab in Patients With ...

author_avatar
NASDAQ Market News

Medical Second Opinion Market Forecast to 2027 – COVID-19 Impact and Global Analysis By Disorder ; Service Providers ; and Geography

author_avatar
NASDAQ Market News